Saturday 17 October 2026 Export UTHR’s income statement to Excel — free account

United Therapeutics Corporation

UTHR Healthcare Drug Manufacturers Specialty & Generic

United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024. In the quarter to June 2026, revenue fell 1.92%, EPS grew 14.0% and free cash flow grew 58.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

533.12 8.39 −1.55%

Follow UTHR

Alert me

Market cap: $23.2B
P/E: 17.6×
Fwd P/E: 20.1×
Dividend yield: —
F-score: 8/9
Altman Z: 19.55
Beneish M: −2.26
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	17.89	20.22	16.14	14.70	+8 more quarters Free account
P/S ratio Full definition →	7.32	8.14	6.78	5.87
P/FCF ratio Full definition →	21.22	25.50	20.85	16.52
P/Operating CF Full definition →	73.60	55.68	62.35	32.67
P/B ratio Full definition →	3.61	4.37	3.04	2.79
Price to Tangible BV Full definition →	3.67	4.46	3.09	2.84
EV/Sales Full definition →	6.57	7.55	5.96	5.08
EV/EBITDA Full definition →	13.88	15.71	12.02	10.08
EV/Operating CF Full definition →	12.30	15.31	12.15	10.21
EV/FCF Full definition →	19.05	23.67	18.32	14.30
Quick Ratio Full definition →	4.89	4.12	5.83	5.61
Current Ratio Full definition →	5.73	4.79	6.60	6.40
Net Debt/EBITDA Full definition →	(7.50)	(6.18)	(7.70)	(6.74)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.42	0.44	0.42	0.43
Operating CF/Net income Full definition →	0.94	1.69	0.95	1.66
Capex/Depreciation Full definition →	(4.46)	(4.46)	(7.58)	(9.86)
Interest Coverage Full definition →	114.07	108.60	115.06	129.50
Research and Development Expense of Revenue Full definition →	18.68%	17.68%	17.65%	15.95%
Selling, General and Administrative Expense of Revenue Full definition →	26.39%	23.56%	24.12%	22.84%
Intangible Assets out of Total Assets Full definition →	0.02	0.02	0.01	0.02
Share Based Compensation of Revenue Full definition →	5.54%	4.34%	4.94%	4.89%
Graham Net Nets Full definition →	0.12	0.08	0.14	0.15
Graham Number Full definition →	319.94	299.15	329.81	310.67
Earnings Yield Full definition →	5.59%	4.94%	6.19%	6.80%
Free Cash Flow Yield Full definition →	4.71%	3.92%	4.80%	6.05%
Revenue per Share Full definition →	18.39	17.97	17.84	18.25
Operating CF per Share Full definition →	7.36	10.65	7.81	12.83
Capex per Share Full definition →	(2.54)	(2.32)	(3.90)	(4.93)
Free Cash Flow per Share Full definition →	4.83	8.33	3.91	7.90
Cash per Share Full definition →	62.50	49.51	65.92	63.19
Shareholders Equity per Share Full definition →	150.24	135.66	160.19	150.46
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	150.24	135.66	160.19	150.46
Free Cash Flow Full definition →	205.60	362.50	173.30	346.10
Working Capital Full definition →	2,875.90	2,272.90	3,141.90	2,947.70
Capital Expenditures Full definition →	(108.00)	(100.80)	(172.90)	(216.00)
Net Current Asset Value Full definition →	2,663.90	2,058.90	2,918.70	2,733.10
EV/EBIT Full definition →	14.78	16.68	12.71	10.64
Capex to Sales Full definition →	0.14	0.13	0.22	0.27
Price to Operating Income Full definition →	16.47	17.97	14.46	12.29
Other line items
Average Receivables Full definition →	344.80	317.00	314.75	319.75
Average Payables Full definition →	464.90	432.65	416.25	415.95
Average Inventory Full definition →	181.50	171.85	170.50	161.60
Average Assets Full definition →	7,564.05	7,229.05	7,622.00	7,237.10
Average Common Equity Full definition →	6,786.95	6,354.15	6,770.10	6,345.55

Show all line items

Columns are period end dates

Stockrow Weekly